1Y Close · As of Aug 26, 2026
GemVax & KAEL operates in the Machinery & Equipment sector.
Legal name: GemVax & KAEL Co.,Ltd.
In fiscal year 2025, GemVax & KAEL (082270) reported revenue of 81.5 billion KRW, up 30.1% from 62.7 billion KRW a year earlier.
Operating profit was 3.8 billion KRW and net income was -11.3 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 483.4 billion KRW, with a P/B of 7.75.
These figures can be verified in the DART filing (receipt no. 20260320001156).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 81.5B | 3.8B | -11.3B |
| 2024 | 62.7B | -38.3B | -87.2B |
| 2023 | 72.2B | -7.9B | -27.2B |
Recent Filings
Officer/Major Shareholder Ownership Report
Securities Issuance Result (Voluntary Disclosure)
Large Shareholding Report (General)
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Treasury Stock: No treasury stock filings.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-28 | Officer/Major Shareholder Ownership Report |
| 2026-08-20 | Securities Issuance Result (Voluntary Disclosure) |
| 2026-08-20 | Large Shareholding Report (General) |
| 2026-08-18 | Officer/Major Shareholder Ownership Report |
| 2026-08-14 | Semi-Annual Report (2026.06) |